Number of shares and votes in Orexo
2016年11月1日 - 2:06AM
ビジネスワイヤ(英語)
The number of shares and votes in Orexo AB has changed as a
result of the exercise of warrants in connection with the company’s
incentive programs and, as previous announced, by issue and
repurchase of class C shares.
Today, the last trading day of the month, there are in total
34,870,326 shares - whereof 34,535,326 are ordinary shares and
335,000 class C shares - and 34,568,826 votes in the company.
About Orexo
Orexo is a specialty pharmaceutical company commercializing its
proprietary product Zubsolv® for treatment of opioid dependence in
the US. Zubsolv is an advanced formulation of buprenorphine and
naloxone using Orexo’s unique knowledge and expertise in sublingual
drug delivery. R&D is focusing on reformulation of known
substances to new improved products that meet great unmet medical
needs by using its patented proprietary technologies. Orexo’s
share is listed on Nasdaq Stockholm Exchange Mid Cap (STO: ORX) and
is available as ADRs on OTCQX (ORXOY) in the US. Orexo’s global
headquarters and R&D are based in Uppsala, Sweden.
For more information about Orexo, please visit www.orexo.com or
follow us on Twitter or LinkedIn. For further information about
Zubsolv in the US, please visit www.zubsolv.com.
The information was submitted for publication at 6:00pm CET,
October 31, 2016
This information was brought to you by Cision
http://news.cision.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161031005972/en/
Henrik Juuel, EVP and CFOTel: 018 780 88 00email:
ir@orexo.comorLena Wange, IR & Communications ManagerTel: 018
780 88 00email: ir@orexo.com
Orefinders Resources (TSXV:ORX)
過去 株価チャート
から 11 2024 まで 12 2024
Orefinders Resources (TSXV:ORX)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Orefinders Resources Inc (トロントベンチャー取引所): 0 recent articles
その他のOrefinders Resources Inc.ニュース記事